v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Class A common stock
Class B common stock
Common Stock
Common Stock
Class A common stock
Common Stock
Class B common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance (in shares) at Dec. 31, 2022         120,006,757 19,937,500      
Balance at Dec. 31, 2022 $ 358,706       $ 12 $ 2 $ 758,366 $ 0 $ (399,674)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options (in shares)         1,825,660        
Common stock issued upon exercise of stock options 357           357    
Stock-based compensation 8,516           8,516    
Net unrealized (loss) gain on marketable securities, net of tax 0                
Foreign currency translation adjustment 0                
Net loss (95,960)               (95,960)
Balance (in shares) at Dec. 31, 2023         121,832,417 19,937,500      
Balance at Dec. 31, 2023 271,619       $ 12 $ 2 767,239 0 (495,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options (in shares)         598,689        
Common stock issued upon exercise of stock options 1,072     $ 1     1,071    
Common stock issued upon vesting of restricted stock units (in shares)         1,096,515        
Common stock issued upon vesting of restricted stock units 1     1          
Common stock issued from at-the-market offering, net of commissions and issuance costs (in shares)         23,425,650        
Common stock issued from at-the-market offering, net of commissions and issuance costs 34,789     2     34,787    
Stock-based compensation 8,887           8,887    
Net unrealized (loss) gain on marketable securities, net of tax 70             70  
Refund of issuance costs 14           14    
Foreign currency translation adjustment (25)             (25)  
Net loss (101,007)               (101,007)
Balance (in shares) at Dec. 31, 2024   146,953,271 19,937,500   146,953,271 19,937,500      
Balance at Dec. 31, 2024 215,420       $ 16 $ 2 811,998 45 (596,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options (in shares)         830,228        
Common stock issued upon exercise of stock options 1,912           1,912    
Common stock issued upon vesting of restricted stock units (in shares)         3,082,653        
Common stock issued upon vesting of restricted stock units 1     1          
Common stock issued from at-the-market offering, net of commissions and issuance costs (in shares)         45,565,121        
Common stock issued from at-the-market offering, net of commissions and issuance costs 93,510     $ 3     93,507    
Stock-based compensation 10,773           10,773    
Net unrealized (loss) gain on marketable securities, net of tax (63)             (63)  
Foreign currency translation adjustment 12             12  
Net loss (101,339)               (101,339)
Balance (in shares) at Dec. 31, 2025   196,431,273 19,937,500   196,431,273 19,937,500      
Balance at Dec. 31, 2025 $ 220,226       $ 20 $ 2 $ 918,190 $ (6) $ (697,980)